Novartis selected Salesforce Agentforce Life Sciences for a five-year global rollout of unified customer engagement.
Novartis had fragmented engagement across marketing, sales, patient services, medical and market access. It will roll out Agentforce Life Sciences, building on Agentforce Health, Data 360 and MuleSoft for Life Sciences. The announcement gives no measured results.
Salesforce is a CRM and cloud platform vendor whose Life Sciences Cloud and Agentforce are used by pharma and medtech for HCP engagement, patient services and clinical operations
This sits in the Design & Stress-Test stage of the AI use-case lifecycle: Named examples from the tools pharma teams use to scope, prototype and benchmark an AI use case before committing to build it — data-catalog, sandbox and evaluation platforms.
Published by Salesforce on its own site — read the original case study on salesforce.com ↗
Note: Press release about a selection and planned rollout, not a results story.
Related use cases
- 01Hansa Biopharma went live on Agentforce Life Sciences in under six weeks for a unified view of field interactions.
- 02Fidia and Pfizer were named early adopters of Salesforce Life Sciences Cloud for customer engagement.
- 03Protas, CliniLink and Mirum run clinical trial and patient services workflows on Salesforce Life Sciences Cloud.
- 04Novo Nordisk Transforms Clinical Trials With AI
- 05How Regeneron is discovering new treatments with AI
- 06How AI is changing drug discovery